Lu-Bin Lan

2.4k total citations
19 papers, 2.0k citations indexed

About

Lu-Bin Lan is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Lu-Bin Lan has authored 19 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Lu-Bin Lan's work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Lu-Bin Lan is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Lu-Bin Lan collaborates with scholars based in United States, Israel and China. Lu-Bin Lan's co-authors include John D. Schuetz, Erin G. Schuetz, Richard B. Kim, Brian P. Sorrentino, Sheng Zhou, Brenda F. Leake, Kazuto Yasuda, Wilfred D. Stein, Steven Wrighton and Frank J. Gonzalez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Lu-Bin Lan

19 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lu-Bin Lan United States	16	1.1k	746	549	379	206	19	2.0k
J. Greg Slatter United States	21	666 0.6×	762 1.0×	540 1.0×	166 0.4×	94 0.5×	50	1.9k
P Maurel France	12	1.1k 1.0×	914 1.2×	1.7k 3.1×	631 1.7×	171 0.8×	17	3.1k
Kari M. Morrissey United States	18	777 0.7×	512 0.7×	334 0.6×	336 0.9×	67 0.3×	25	1.5k
Isabelle Dussault United States	23	1.4k 1.2×	1.0k 1.4×	684 1.2×	193 0.5×	94 0.5×	65	2.8k
Kouichi Kurose Japan	22	489 0.4×	661 0.9×	456 0.8×	238 0.6×	69 0.3×	54	2.0k
Michel Lemaire Japan	28	952 0.8×	619 0.8×	279 0.5×	699 1.8×	116 0.6×	62	2.4k
Henrik Gréen Sweden	30	980 0.9×	1.1k 1.5×	341 0.6×	150 0.4×	69 0.3×	162	2.9k
Maya K. Leabman United States	16	1.2k 1.1×	675 0.9×	195 0.4×	442 1.2×	158 0.8×	33	2.0k
Léa Payen France	26	1.0k 0.9×	784 1.1×	226 0.4×	330 0.9×	153 0.7×	97	2.1k
Bill J. Smith United States	20	697 0.6×	467 0.6×	348 0.6×	327 0.9×	48 0.2×	28	1.6k

Countries citing papers authored by Lu-Bin Lan

Since Specialization

Citations

This map shows the geographic impact of Lu-Bin Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu-Bin Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu-Bin Lan more than expected).

Fields of papers citing papers by Lu-Bin Lan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu-Bin Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu-Bin Lan. The network helps show where Lu-Bin Lan may publish in the future.

Co-authorship network of co-authors of Lu-Bin Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Lu-Bin Lan. A scholar is included among the top collaborators of Lu-Bin Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu-Bin Lan. Lu-Bin Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Li, Jing Jing, Bin Wang, Chao Chen, et al.. (2018). In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation. Journal of Neuroinflammation. 15(1). 8–8. 177 indexed citations

2.

Xue, Yue-Qiang, Tao Ma, Xiaofang Wang, et al.. (2015). Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Molecular Neurodegeneration. 10(1). 24–24. 94 indexed citations

3.

Wolf, Kristina, Sheryl G. Wood, Jane A. Hunt, et al.. (2005). ROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY. Drug Metabolism and Disposition. 33(12). 1827–1836. 37 indexed citations

4.

Masson, David, Laurent Lagrost, Anne Athias, et al.. (2005). Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid–Mediated Changes in Plasma Lipoprotein Profile. Arteriosclerosis Thrombosis and Vascular Biology. 25(10). 2164–2169. 30 indexed citations

5.

Tirona, Rommel G., Wooin Lee, Brenda F. Leake, et al.. (2003). The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nature Medicine. 9(2). 220–224. 361 indexed citations

6.

Schuetz, Erin G., Lu-Bin Lan, Kazuto Yasuda, et al.. (2002). Development of A Real-Time in Vivo Transcription Assay: Application Reveals Pregnane X Receptor-Mediated Induction of CYP3A4 by Cancer Chemotherapeutic Agents. Molecular Pharmacology. 62(3). 439–445. 44 indexed citations

7.

Yasuda, Kazuto, Lu-Bin Lan, Dominique Sanglard, et al.. (2002). Interaction of Cytochrome P450 3A Inhibitors with P-Glycoprotein. Journal of Pharmacology and Experimental Therapeutics. 303(1). 323–332. 117 indexed citations

8.

Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein. Molecular Pharmacology. 61(5). 964–973. 138 indexed citations

9.

Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and Substrates. Molecular Pharmacology. 61(5). 974–981. 30 indexed citations

10.

Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Application of Three-Dimensional Quantitative Structure-Activity Relationships of P-Glycoprotein Inhibitors and Substrates. Molecular Pharmacology. 61(5). 974–981. 155 indexed citations

11.

Ekins, Sean, Richard B. Kim, Brenda F. Leake, et al.. (2002). Three-Dimensional Quantitative Structure-Activity Relationships of Inhibitors of P-Glycoprotein. Molecular Pharmacology. 61(5). 964–973. 16 indexed citations

12.

Zhou, Sheng, et al.. (2002). Bcrp1gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cellsin vivo. Proceedings of the National Academy of Sciences. 99(19). 12339–12344. 411 indexed citations

13.

Lan, Lu-Bin, James T. Dalton, & Erin G. Schuetz. (2000). Mdr1Limits CYP3A Metabolism in Vivo. Molecular Pharmacology. 58(4). 863–869. 73 indexed citations

14.

Lecureur, Valérie, Daxi Sun, Erin G. Schuetz, et al.. (2000). Cloning and Expression of Murine Sister of P-Glycoprotein Reveals a More Discriminating Transporter ThanMDR1/P-Glycoprotein. Molecular Pharmacology. 57(1). 24–35. 90 indexed citations

15.

Lan, Lu-Bin, James T. Dalton, & Erin G. Schuetz. (2000). Mdr1 Limits CYP3A Metabolism in Vivo. Molecular Pharmacology. 58(4). 863–869. 6 indexed citations

16.

Scala, Stefania, U.S. Mahadeva Rao, K Paull, et al.. (1997). P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct Groups. Molecular Pharmacology. 51(6). 1024–1033. 201 indexed citations

17.

Lan, Lu-Bin, et al.. (1996). Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing. Cancer Chemotherapy and Pharmacology. 38(2). 181–190. 29 indexed citations

18.

Lyubimov, Elena, et al.. (1996). Effect of modulators of the multidrug resistance pump on the distribution of vinblastine in tissues of the mouse. Anti-Cancer Drugs. 7(1). 60–69. 12 indexed citations

19.

Lyubimov, Elena, et al.. (1995). Saturation reversal of the multidrug pump using many reversers in low-dose combinations. Anti-Cancer Drugs. 6(6). 727–735. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact